Ozurdex dexamethasone intravitreal implant regulatory update

FDA approved an sNDA from Allergan for Ozurdex dexamethasone intravitreal implant to treat non-infectious uveitis affecting the posterior segment of the eye. The biodegradable implant is already appro...